Karen E. Schultz1, George K. Lui1,2, Doff B. McElhinney1, Jin Long3, Vidhya Balasubramanian3, Charlotte Sakarovitch3, Susan M. Fernandes1,2, Anne M. Dubin1, Ian S. Rogers1,2, Anitra W. Romfh1,2, Kara S. Motonaga1, Mohan N. Viswanathan2, Scott R. Ceresnak1
Congenital Heart Disease, Vol.14, No.3, pp. 410-418, 2019, DOI:10.1111/chd.12736
Abstract Background: Arrhythmias are a leading cause of death in adults with congenital heart
disease (ACHD). While 24‐48‐hour monitors are often used to assess arrhythmia
burden, extended continuous ambulatory rhythm monitors (ECAM) can record 2
weeks of data. The utility of this device and the arrhythmia burden identified beyond
48‐hour monitoring have not been evaluated in the ACHD population. Additionally,
the impact of ECAM has not been studied to determine management
recommendations.
Objective: To address the preliminary question, we hypothesized that clinically sig‐
nificant arrhythmias would be detected on ECAM beyond 48 hours and this would
lead to clinical management changes.
… More >
Login
Register
